I. Ahmad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
I. Ahmad has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
E. Kostantin
Biochemistry, Hôpital Maisonneuve-Rosemont, Université de Montréal, Montreal, QC, Canada
1 shared publicationG. J. Tsongalis
Department of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center and The Audrey and Theodor Geisel School of Medicine at Dartmouth, Lebanon, NH, USA
1 shared publicationJ. Roy
Haematology and Medical Oncology, Hôpital Maisonneuve-Rosemont, Université de Montréal, Montreal, QC, Canada
1 shared publicationM. Guimond
Department of Microbiology, Infectious Diseases & Immunology, Université de Montréal, Montreal, QC, Canada
1 shared publicationM. Newmarch
Haematology and Medical Oncology, Hôpital Maisonneuve-Rosemont, Université de Montréal, Montreal, QC, Canada
1 shared publication- Vincent De Guire
Clinical Biochemistry Department and Research Center of Maisonneuve-Rosemont Hospital , Department of Biochemistry and Molecular Medicine of the Université de Montréal , Montreal , QC , Canada
1 shared publication
Latest Publications
- 3 December 2019
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 55 (6) , 1014-1020
MicroRNAs in graft-versus-host disease: a review of the latest data
Detectable in biopsies and body fluids, the measurement of a single or panels of microRNAs have been reported to be quite sensitive and specific for the prediction, diagnosis, and prognosis of many diseases. Interest in the use of microRNAs as biomarkers and eventual therapeutic targets has increased exponentially in the last decade. However, in the field of graft-versus-host disease (GVHD), the discovery of their involvement in biological processes and their predictive value is only emerging. With 30–75% of patients developing GVHD following allogeneic hematopoietic cell transplant and the absence of routinely used predictive biomarkers, microRNAs are promising for early detection and follow-up of this condition. We aim to summarize the current knowledge on the involvement of these small RNAs in the pathophysiology of this disease. We also review studies investigating the potential of miRNAs as biomarkers for early detection, follow-up, and prognosis of GVHD.
- 3 December 2019
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 55 (6) , 1014-1020
MicroRNAs in graft-versus-host disease: a review of the latest data
Detectable in biopsies and body fluids, the measurement of a single or panels of microRNAs have been reported to be quite sensitive and specific for the prediction, diagnosis, and prognosis of many diseases. Interest in the use of microRNAs as biomarkers and eventual therapeutic targets has increased exponentially in the last decade. However, in the field of graft-versus-host disease (GVHD), the discovery of their involvement in biological processes and their predictive value is only emerging. With 30–75% of patients developing GVHD following allogeneic hematopoietic cell transplant and the absence of routinely used predictive biomarkers, microRNAs are promising for early detection and follow-up of this condition. We aim to summarize the current knowledge on the involvement of these small RNAs in the pathophysiology of this disease. We also review studies investigating the potential of miRNAs as biomarkers for early detection, follow-up, and prognosis of GVHD.